These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15659298)

  • 1. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain.
    Christoph T; Kögel B; Schiene K; Méen M; De Vry J; Friderichs E
    Eur J Pharmacol; 2005 Jan; 507(1-3):87-98. PubMed ID: 15659298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
    Tzschentke TM; Christoph T; Kögel B; Schiene K; Hennies HH; Englberger W; Haurand M; Jahnel U; Cremers TI; Friderichs E; De Vry J
    J Pharmacol Exp Ther; 2007 Oct; 323(1):265-76. PubMed ID: 17656655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia.
    Szolcsányi J; Bölcskei K; Szabó A; Pintér E; Petho G; Elekes K; Börzsei R; Almási R; Szuts T; Kéri G; Helyes Z
    Eur J Pharmacol; 2004 Sep; 498(1-3):103-9. PubMed ID: 15363982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nefopam and ketoprofen synergy in rodent models of antinociception.
    Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
    Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T; De Vry J; Tzschentke TM
    Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
    Bomholt SF; Mikkelsen JD; Blackburn-Munro G
    Neuropharmacology; 2005 Feb; 48(2):252-63. PubMed ID: 15695164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preclinical comparison between different opioids: antinociceptive versus adverse effects.
    Meert TF; Vermeirsch HA
    Pharmacol Biochem Behav; 2005 Feb; 80(2):309-26. PubMed ID: 15680184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents.
    Khroyan TV; Polgar WE; Orduna J; Zaveri NT; Judd AK; Tuttle DJ; Sanchez A; Toll L
    Eur J Pharmacol; 2007 Mar; 560(1):29-35. PubMed ID: 17303110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain.
    Stöhr T; Krause E; Selve N
    Eur J Pain; 2006 Apr; 10(3):241-9. PubMed ID: 15946870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic efficacy of orally administered buprenorphine in rats.
    Martin LB; Thompson AC; Martin T; Kristal MB
    Comp Med; 2001 Feb; 51(1):43-8. PubMed ID: 11926301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic.
    Cooper DM; Hoffman W; Wheat N; Lee HY
    Comp Med; 2005 Aug; 55(4):344-53. PubMed ID: 16158910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
    Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
    Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model.
    Lynch JJ; Wade CL; Zhong CM; Mikusa JP; Honore P
    Pain; 2004 Jul; 110(1-2):56-63. PubMed ID: 15275752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.